We are live on ! Find out more
NC

nVerses Capital Portfolio holdings

AUM $65M
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$126M
Cap. Flow
+$127M
Cap. Flow %
75.78%
Top 10 Hldgs %
5.28%
Holding
1,254
New
650
Increased
227
Reduced
96
Closed
275

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$947K
2
HBAN icon
Huntington Bancshares
HBAN
+$943K
3
CNC icon
Centene
CNC
+$917K
4
AEP icon
American Electric Power
AEP
+$901K
5
MNST icon
Monster Beverage
MNST
+$891K

Top Sells

Rank Stock Value
1
CNP icon
CenterPoint Energy
CNP
+$239K
2
DBX icon
Dropbox
DBX
+$236K
3
CMRE icon
Costamare
CMRE
+$232K
4
CMS icon
CMS Energy
CMS
+$229K
5
SEB icon
Seaboard Corp
SEB
+$226K

Sector Composition

Rank Sector Weight
1 Technology 19.1%
2 Industrials 17.26%
3 Financials 14.35%
4 Consumer Discretionary 14.25%
5 Healthcare 11.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHK icon
151
Mohawk Industries
MHK
$9.27B
$363K 0.22%
+3,200
New +$372K
AGCO icon
152
AGCO
AGCO
$7.11B
$362K 0.22%
+3,700
New +$412K
UNM icon
153
Unum
UNM
$14.5B
$358K 0.21%
+7,000
New +$362K
SNAP icon
154
Snap
SNAP
$8.96B
$357K 0.21%
+21,500
New +$308K
EVR icon
155
Evercore
EVR
$11.5B
$354K 0.21%
+1,700
New +$331K
XYL icon
156
Xylem
XYL
$28.5B
$353K 0.21%
+2,600
New +$354K
F icon
157
Ford
F
$55.4B
$351K 0.21%
28,000
+27,200
+3,400% +$336K
BMY icon
158
Bristol-Myers Squibb
BMY
$132B
$349K 0.21%
+8,400
New +$376K
INSM icon
159
Insmed
INSM
$28.9B
$348K 0.21%
+5,200
New +$202K
SRPT icon
160
Sarepta Therapeutics
SRPT
$1.94B
$348K 0.21%
2,200
+1,700
+340% +$218K
MKL icon
161
Markel Group
MKL
$22.8B
$347K 0.21%
+220
New +$342K
BPMC
162
DELISTED
Blueprint Medicines
BPMC
$345K 0.21%
3,200
+3,100
+3,100% +$310K
JEF icon
163
Jefferies Financial Group
JEF
$12.9B
$343K 0.21%
+6,900
New +$310K
ATKR icon
164
Atkore
ATKR
$3.17B
$337K 0.2%
+2,500
New +$398K
FRPT icon
165
Freshpet
FRPT
$3.48B
$336K 0.2%
+2,600
New +$312K
FCFS icon
166
FirstCash
FCFS
$9.28B
$336K 0.2%
+3,200
New +$378K
LEA icon
167
Lear
LEA
$8.16B
$331K 0.2%
2,900
+2,800
+2,800% +$358K
MEDP icon
168
Medpace
MEDP
$16.2B
$329K 0.2%
+800
New +$317K
LAD icon
169
Lithia Motors
LAD
$8.32B
$328K 0.2%
+1,300
New +$340K
VRTX icon
170
Vertex Pharmaceuticals
VRTX
$133B
$328K 0.2%
+700
New +$304K
PPC icon
171
Pilgrim's Pride
PPC
$6.4B
$327K 0.2%
8,500
+6,700
+372% +$242K
CHE icon
172
Chemed
CHE
$7.02B
$326K 0.19%
+600
New +$344K
PLNT icon
173
Planet Fitness
PLNT
$3.65B
$324K 0.19%
+4,400
New +$285K
MRK icon
174
Merck
MRK
$328B
$322K 0.19%
2,600
+2,100
+420% +$271K
AVGO icon
175
Broadcom
AVGO
$1.99T
$321K 0.19%
+2,000
New +$280K
5 6
7
8 9

Similar funds

PFO
PMC FIG Opportunities Jerusalem, Israel $65M AUM 43.12% 1-Year Est. Return
1M
13D Management New York $64.5M AUM 38.54% 1-Year Est. Return
ILCM
Ivy Lane Capital Management Winter Park, Florida $66.1M AUM 28.52% 1-Year Est. Return
SGOM
SIP Global Opportunity Manager Portsmouth, New Hampshire $66.3M AUM
RC
Rithm Capital New York $67.4M AUM 37.43% 1-Year Est. Return
HPCM
Hein Park Capital Management New York $61.3M AUM 14.47% 1-Year Est. Return
CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
YEPX
Yorktown Energy Partners X New York $69.5M AUM 143.07% 1-Year Est. Return

nVerses Capital's Q2 2024 Portfolio in Review

As of Q2 2024, nVerses Capital held 1,254 positions worth $167M, up 302% from $41.7M the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

nVerses Capital deployed $127M of net new capital in Q2 2024, opening 650 new positions and adding to 227 existing holdings. Its largest new stake was Stellantis: 40,900 shares worth $812K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Costamare, an estimated $232K trimmed.

  • nVerses Capital's largest Q2 2024 buy was Stellantis: 40,900 shares worth $812K.
  • nVerses Capital added most to Centene in Q2 2024, an estimated $917K increase.
  • nVerses Capital's biggest Q2 2024 reduction was Costamare, cutting an estimated $232K.
  • nVerses Capital fully exited CenterPoint Energy in Q2 2024, selling an estimated $239K.
  • nVerses Capital's ten largest holdings make up 5.3% of its $167M portfolio in Q2 2024.
  • nVerses Capital opened 650 new positions and closed 275 in Q2 2024.
  • nVerses Capital's portfolio value rose 302% quarter-over-quarter to $167M.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.